FDA approves new formulation, indication for Merck’s DificidMerck has received the FDA's blessing for a pediatric indication for Dificid, as well as an oral suspension formulation. Pfizer to launch 3 biosimilarsPfizer is the first company to launch three oncology monoclonal antibody (mAb) biosimilar treatments. Micro Labs, Saptalis ink generics deal, launch first product Micro Labs USA and Saptalis Pharmaceuticals have formed a strategic collaboration to launch single-source and multisource generics in the United States. Merck to acquire ArQule Merck’s acquisition of ArQule diversifies its oncology pipeline. Grifols launches Xembify Grifol’s Xembify is the first 20% subcutaneous immunoglobulin for primary immunodeficiency treatment. Kroger pharmacies offering strep, flu testing in 2 states Kroger Health pharmacies in Idaho and Michigan are providing rapid strep throat and flu tests carried out by pharmacists on a walk-in basis. Ironwood, Allergan settle patent suit with Teva The earliest licensed entry of any generic linaclotide 145 mcg or 290 mcg Linzess is March 2029. NACDS to CMS: Executive Order 13890 relies on leveraging pharmacy NACDS’ comments to CMS demonstrate that success of healthcare transformation relies on removing barriers to pharmacy care. PQA names 2020 board and executive committee PQA appointed Linda Garrelts MacLean and Michael Taday to its 21-member board, as well as named a new executive board. Alembic gets FDA nod for generic Zanaflex Tizanidine hydrochloride had a market value of roughly $28 million for the 12 months ended September 2019, according to IQVIA. First Previous 414 415 416 417 418 Next Last